Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am a LONG and from the looks of this company, I am definetly in it for a LONG time , lolol Sitting on 31,000,000 shares I bought at .0001 way back in Dec./Jan. I have it all set up to sell in many increments,so if I am climbing Mt. Everest or paddling down the Congo River or swimming the English Channel, then I don't have to watch this PAINFULL show that goes on here daily!! GLTA :)
Any one have any idea of what is going on with MGLG? Not speculation, but for sure ideas? I am a long and I am still waiting like the rest of you for some NEWS, GOOD NEWS, BAD NEWS.....ANY NEWS! My measly 10,000,000 shares would like to make me some nice money B4 I DIE of OLD AGE!!!!
Well,I have 700,000 shares that I have had for quite awhile. I have an order in for 300,000 @ .006 and 100,000 @ .005 , so I hope it drops down so I can get some more at those prices. Then let it SKY ROCKET !!! . :)
Well, I still have my 31,000,000 shares, and I am still holding long. Been holding these for almost a year. When it does rise , mine won't start selling til at least .0007 to .005 I am very patient with this stock. :)
I am not PUMPING when I say it can only go up. I have 31m shares I bought way back when. I am a long and I "hope" that it moves up. Small increments are fine, as long as it moves. It does NOT have to start moving tomorrow, but sometime in the future. Now you can question me on what I have said, and I stand by it, I have stated it is JMHO. I don't have PROOF, thats why I said I think it will go up because it has no where else to go but up. I don't have a lot of confidence in this company anymore, but I have high HOPES! that my 31m shares can make me a little profit in the future.
Late last year or early this year, they had stated that they would start production late this year or early next year. I think it will be late Nov or Dec and production will start. Then we will have one helluva Christmas present!!! JMHO
I got in quite awhile back, either early this year or late last year. I did some DD and decided on taking a little gamble. Bought 30,000,000 at that time and picked up another 1 mil along the way. $3,100 total. Not a whole lot of money, just a drop in the bucket compared to all my investments. Just wish this stock would move up steadily into penny land. I would settle for 1 or 2 cents! lol :)
Interesting, any and all good news is a welcomed sight for our stock. I don't have a lot of shares (9,000), but good news is always better than bad news! :)
lolol, it can't go much lower with out disappearing. Good news is, it has a good chance of moving up, just don't know when. Still holding 31,000,000 shares I got at .0001
:)
PERFECT!!!! I got another 125,000 shares @ .0083 !!! Now I have a total of 700,000 shares! LET THIS BABY RISE ANYTIME IT WANTS! Can't wait til production starts ! me happy me happy me happy :) GLTUA
I myself would like to see it drop to .0087 or lower for awhile,then maybe I can get the order I have for 125k more shares. I then would be happy to see it STEADILY climb as high as you all want it to. That would give me 700k shares. So.... lets make me happy! :)
Wow Kapla, I was ready to correct you on the stem research, but then I realised that STEM and ACTC are working on the same things. I own stock in both companies. GLTA! :)
I am not negative, just factual. Yes , I am a long, but for this to run w/o production, shows me this is a pump and dump scheme. Like I said, IF and When they start producing oil/gas , then I will believe. Again JMHO
Price of oil??? This company has not posted any oil production in ions! IF and WHEN they do, then my 1,061,464 shares MIGHT be worth something. So far this is a paper tiger, nothing more until they produce oil/gas.
yada yada yada, wake me up if this ever hits .005 ! looks like I will get lots of sleep.
STEMCELLS NEWS
StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration
Preclinical Data Presented Today at Society for Neuroscience Annual Meeting
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 19, 2009-- StemCells, Inc. (NASDAQ:STEM) announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term. Cones are light sensing cells that are highly concentrated within the macula of the human eye, and the ability to protect these cells suggests a promising approach to treating age-related macular degeneration (AMD), the leading cause of vision loss and blindness in people over the age of 55. These important findings were presented today in Chicago, Illinois at the Society for Neuroscience 2009 Annual Meeting, one of the leading forums for neuroscientists from around the world to present and discuss cutting-edge research in the field.
“We have long recognized that a number of eye disorders may be suitable candidates for stem cell-based therapies,” stated Stephen Huhn, MD, FACS, FAAP, vice president and head of the CNS program at StemCells, Inc. “The demonstrated ability of our human neural stem cells to preserve cones is very meaningful, because it is the progressive deterioration of these specific cells that ultimately results in vision loss in AMD. These data support our hypothesis that our neural stem cells may provide neuroprotection to existing cells, and it is our hope that we will be able to replicate these promising results in the clinic.”
This study, which was conducted in collaboration with researchers from the Casey Eye Institute at Oregon Health & Science University (OHSU), focused on assessing photoreceptor survival and vision preservation following transplantation of StemCells’ human neural stem cells. Results of the study demonstrate that, when transplanted into the eye of the Royal College of Surgeons (RCS) rat, a well-established animal model of retinal degeneration, the neural stem cells preserve visual function as measured by two separate visual tests, and exhibit robust, long-term protection of both rod and cone photoreceptors.
Raymond Lund, Ph.D., professor of Ophthalmology at the Casey Eye Institute, commented, “My lab has been involved in researching many cell therapy approaches for diseases of the eye, and the results we have seen with the human neural stem cell are particularly exciting. This study provides novel evidence that neural stem cells may provide significant therapeutic value for clinical cases of retinal degeneration, and we look forward to testing their potential in additional studies with StemCells, Inc.”
The eye contains millions of photoreceptor cells, known as rods and cones, which are responsible for picking up light and converting it into electrical impulses that are sent along the optic nerve for the brain to interpret what we see. Rods allow us to see under dark conditions, while cones allow us to see color and fine detail. Cones are highly concentrated within the macula, the part of the eye that is responsible for our central, “straight ahead” vision. Patients with AMD lose central vision when the cones within the macula degenerate. It is estimated that 25 – 30 million people worldwide suffer from AMD, including as many as 15 million Americans, and today there is no cure.
StemCells is pursuing additional preclinical studies of its neural stem cells in the hope of one day achieving a breakthrough in treating AMD. The encouraging results of this latest study follow previously reported data showing that StemCells’ neural stem cells engraft, survive long term, and can protect the retina from progressive degeneration in the RCS rat. StemCells is currently developing its human neural stem cells as a potential therapeutic product, HuCNS-SC® cells, for multiple degenerative disorders of the central nervous system.
About HuCNS-SC® Cells
StemCells’ lead product candidate, HuCNS-SC cells, is a highly purified composition of human neural stem cells that are expanded and stored as banks of cells. The Company’s preclinical research has shown that HuCNS-SC cells can be directly transplanted in the central nervous system. The transplanted cells are able to engraft, migrate, differentiate into neurons and glial cells, and possess the ability to survive for as long as one year with no sign of tumor formation or adverse effects. These findings show that HuCNS-SC cells, when transplanted, behave like normal stem cells, suggesting the possibility of a continual replenishment of normal human neural cells.
StemCells recently completed a Phase I clinical trial of its HuCNS-SC cells for the treatment of a Neuronal Ceroid Lipofuscinosis (NCL), a fatal brain disorder in children. Data from this trial demonstrated the safety and tolerability of these cells. StemCells has also announced that it will soon initiate at the University of California, San Francisco (UCSF) Children’s Hospital a Phase I trial of the HuCNS-SC cells in Pelizaeus-Merzbacher Disease (PMD), a fatal myelination disorder that primarily affects young children. The human safety data that StemCells is accumulating for its HuCNS-SC cells through these clinical trials is expected to facilitate the pathway for future clinical testing in other central nervous system disorders, including retinal degenerative diseases such as AMD and retinitis pigmentosa.
About StemCells, Inc.
StemCells, Inc. is focused on the development and commercialization of cell-based technologies. In its cellular medicine programs, StemCells is targeting diseases of the central nervous system and liver. StemCells’ lead product candidate, HuCNS-SC® cells (purified human neural stem cells), is in clinical development for the treatment of two fatal neurodegenerative disorders that primarily affect young children. StemCells also markets specialty cell culture media products under the brand SC Proven®, and is developing its cell-based technologies for use in drug screening and drug development. The Company has exclusive rights to approximately 55 issued or allowed U.S. patents and approximately 200 granted or allowed non-U.S. patents. Further information about StemCells is available on its web site at www.stemcellsinc.com.
About OHSU and Casey Eye Institute
Oregon Health & Science University is the state's only health and research university, and Oregon's only academic health center. OHSU is Portland's largest employer and the fourth largest in Oregon (excluding government). OHSU's size contributes to its ability to provide many services and community support activities not found anywhere else in the state. It serves patients from every corner of the state, and is a conduit for learning for more than 3,400 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to every county in the state.
The Casey Eye Institute, named after the founders of United Parcel Service, opened on the OHSU Marquam Hill Campus in 1991. The Casey Eye Institute is an academic regional eye center dedicated to preventing blindness through research, and to bringing advanced technology to the Pacific Northwest through continuing education of physicians. Casey is the seventh and final regional eye research center in the nation sponsored by Research to Prevent Blindness, the world's leading voluntary organization in support of eye research.
Apart from statements of historical fact, the text of this press release constitutes forward-looking statements regarding, among other things, the potential of the Company’s neural stem cells to treat retinal disorders such as AMD, the Company’s plans to pursue additional studies of its neural stem cells for the treatment of retinal disorders, and the prospects for future commercialization of a product to treat retinal disorders. These forward-looking statements speak only as of the date of this news release. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Such statements reflect management’s current views and are based on certain assumptions that may or may not ultimately prove valid. The Company’s actual results may vary materially from those contemplated in such forward-looking statements due to risks and uncertainties to which the Company is subject, including: uncertainties with respect to the fact that additional preclinical studies followed by clinical trials will be required to confirm the safety and demonstrate the efficacy of the Company’s HuCNS-SC cells for the treatment of retinal disorders or any other disease; risks whether the FDA or other applicable regulatory agencies will permit the Company to continue clinical testing of its HuCNS-SC cells in NCL, PMD or in future clinical trials for retinal disorders or other diseases or conditions despite the novel and unproven nature of the Company’s technologies; uncertainties about the design of future clinical trials and whether the Company will receive the necessary support of a clinical trial site and its institutional review board to pursue future clinical trials in NCL, PMD, retinal disorders or in proposed therapies for other diseases or conditions; uncertainties regarding the Company’s ability to obtain the increased capital resources needed to continue its current and planned research and development operations, uncertainty as to whether HuCNS-SC cells and any products that may be generated in the future in the Company’s cell-based programs will prove safe and clinically effective and not cause tumors or other adverse side effects; uncertainties regarding whether results in preclinical research in animals will be indicative of future clinical results in humans; uncertainties regarding the Company’s manufacturing capabilities given its increasing preclinical and clinical commitments; and other factors that are described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 and in its subsequent reports on Form 10-Q and Form 8-K.
Source: StemCells, Inc.
StemCells, Inc.
Megan Meloni, 650-475-3100, ext. 105 (Investors)
or
Vida Communication, Inc.
Tim Brons, 415-675-7402 (Media)
OK , OK, I will tell you all now that I am buying out the company! I can't stand holding off on it any longer. I will be paying .000012 per share. SO, anyone who wants to sell their shares, get in line and stay in an orderly fashion.......... what are you all laughing at!!! get back in line!!!
:)
Not bitter, I still have my original 1,061,464 shares from last year. I just think this is another pump and dump going on. I hope it is not, but I feel it is. And like I said, I won't get my hopes up until I see oil and gas production numbers. GLTA
I would like to know how MMTE can be going up and has not produced any oil or gas that we know of. Last info on oil/gas was back in Jan. 2009 and they were going to replace the man on site because he sold the oil/gas and pocketed the money. I am gonna stay cautious until I see OIL and GAS production. Not just paperwork trails.
WHY is this posted on the I-BOX ! ?
WARNING: Stock is listed as "Caveat Emptor" on Pinksheets.com!
I thought we have explained this until we are blue in the face!? I suggest it be REMOVED!!!
My Zecco acct. also shows 5m traded so far.
I am still holding my 10,000,000 shares. I do believe this is going to turn around. After the SEC fiasco, maybe OUR company will straighten up and fly right! This is just MY OPINION! Do your own DD. Not trying to pump this stock. Just stating MY position. GLTA
My Zecco acct, showed over 3 million traded today. could not get any other info but that.
Heels , I have NO problem with your comments. I do have a problem with pumpers and bashers. Luckily I read these forums not for info, but for drama and comedy! As many should know, I am a long and my pink sheet stocks are not my main stocks. I buy my stocks by DD and not by what is said in the forums!
I have 31,000,000 shares and have had them along time waiting for this company to bust out. I guess it might bust out in 2011 or later. Would love to see it do it sooner, but I doubt it. Luckily I am a long and I have A LOT of patience! :)
jockpot??? lolol, hope its not too sweaty!!! :)
.03 ! jeesh mine would be worth $930,000 lolol
Most class action suits don't pay out much, except to the lawyers and the initial litigants. I have 10m shares also and I am going to wait and see what happens. Hopefully things will turn out ok, whether it be a clean slate for MGLG and our shares are still of value.... or we get our investments back by litigation or settlement. Worst case scenario, I lose $5600.00 and will be much more careful in the future with penny stock investing. I have made approx. $17,000 profit on stocks this year so far, but that is with Nasdaq and DOW stocks like FORD, Toyota ect. So GL 2 All of us affected by this situation.
I have stock in this company, but beware? I also have stock in MGLG and it has been suspended. And THEY had PRs every month to 3 months! So now I am watching this company very closely from now on!
I got in at .0112 back last year for 450,000 shares. I just bought another 125000 shares @ .012 and I am happy and just waiting for when they start production and hits several comstock loads!! GLTA whether you are a flipper or a long. :)
Not an absolute, Have they come out with ANY substantial info?, no. Have they updated any pics of the wells and pumps? no. Have they responded to ANY e-mails sent thru their web site? None of mine have ever been answered. Has ANYONES e-mails been answered? I haven't seen any posted here!
GL 2 all. Last news from this "oil" company was back in Jan. 09 and silence ever since. I have called several times and I have e-mailed many times and NEVER received a RESPONSE from any of them. I still hold over 1,000,000 shares that I keep as a reminder too myself not to believe everything I read, or hear. I hope it does make me some money someday, but I sure ain't holding my breath!!!! :)
I have ZECCO and yes, I can put in a stop limit such as .00051 to .00011. Now, let me say this. I am not happy with some of the news from yesterday. I am greatly disappointed in Karen and MGLG. I am also still holding my 10,000,000 shares that I bought waaay back when. If you want to sell or you want to buy MGLG shares do it. It is YOUR money to invest or not. I am not gonna whine and cry over this BTU problem. I am over 50 yrs. old. I have served my country with the 7th I.D.. I have lived in the Mohave desert. I have chronic kidney stones. I have diabetes. I have a spinal injury and my left hand and left leg does not work well from it. So I have enough problems to worry about than to worry about BTU problems with MGLG and others. Just my 2 cents worth of opinion. :)
received an e-mail from Karen, basically saying this:
shareholder update will be issued next week to coincide with the updated website going live.
Not sure if this helps any of you, but I at least like the fact that she is communicating with us and not staying silent.
Sorry guys but you have the WRONG company. NXHD bought a filming company called Revel Entertainment, not a hotel and casino . 2 completly differant companies. :)
Not bashing, I have 31,000,000 shares of NXHD, but I do read the news carefully!
Longest handle I think I have ever seen on a cup! lol Still holding my 10m shares long! :)
I still have my 31,000,000 shares and waiting on the future. GLTAWQ ( good luck to all who quit)
I am thick skinned, my PATIENCE is just fine! Still holding my original 10,000,000 shares. :)
I think you have missed the boat, I bought in at $2.16 and I am still holding! :)